| scholarly article | Q13442814 |
| P2093 | author name string | Yu Zhao | |
| Dean R Madden | |||
| Brian V Popp | |||
| Zachary T Ball | |||
| Rituparna Kundu | |||
| Patrick R Cushing | |||
| P2860 | cites work | Computational design of a PDZ domain peptide inhibitor that rescues CFTR activity | Q21145315 |
| A Golgi-associated PDZ domain protein modulates cystic fibrosis transmembrane regulator plasma membrane expression | Q24291900 | ||
| Structure-Based Design of an Organoruthenium Phosphatidyl-inositol-3-kinase Inhibitor Reveals a Switch Governing Lipid Kinase Potency and Selectivity | Q27650628 | ||
| Potent inhibitors of HCV-NS3 protease derived from boronic acids | Q27652966 | ||
| Structural basis for the design of novel Schiff base metal chelate inhibitors of trypsin | Q27660118 | ||
| Structurally Sophisticated Octahedral Metal Complexes as Highly Selective Protein Kinase Inhibitors | Q27667351 | ||
| Design of potent selective zinc-mediated serine protease inhibitors | Q27748863 | ||
| Unraveling hot spots in binding interfaces: progress and challenges | Q29614463 | ||
| Bcl-XL-templated assembly of its own protein-protein interaction modulator from fragments decorated with thio acids and sulfonyl azides | Q33371280 | ||
| Structure-selective modification of aromatic side chains with dirhodium metallopeptide catalysts | Q33564837 | ||
| Engineering Peptide Inhibitors To Overcome PDZ Binding Promiscuity | Q33755113 | ||
| Screening of protein-protein interaction modulators via sulfo-click kinetic target-guided synthesis | Q33877498 | ||
| Metallotherapeutics: novel strategies in drug design | Q34775956 | ||
| Plasma membrane CFTR regulates RANTES expression via its C-terminal PDZ-interacting motif | Q34811102 | ||
| Tethering: fragment-based drug discovery | Q35771569 | ||
| Specific inhibition of the transcription factor Ci by a cobalt(III) Schiff base-DNA conjugate | Q35855730 | ||
| Interactions of metal-metal-bonded antitumor active complexes with DNA fragments and DNA. | Q36040618 | ||
| The design of coiled-coil structures and assemblies | Q36101270 | ||
| Design and characterization of the anion-sensitive coiled-coil peptide | Q36280492 | ||
| A decade of fragment-based drug design: strategic advances and lessons learned | Q36732253 | ||
| Orientation and oligomerization specificity of the Bcr coiled-coil oligomerization domain | Q36853551 | ||
| Targeted inhibition of Snail family zinc finger transcription factors by oligonucleotide-Co(III) Schiff base conjugate | Q37310555 | ||
| Metal-directed protein self-assembly | Q37700461 | ||
| 2D NMR spectroscopic evidence for unprecedented interactions of cis-[Rh2(dap)(mu-O2CCH3)2(eta1-O2CCH3)(CH3OH)](O2CCH3) with a DNA oligonucleotide: combination of intercalative and coordinative binding | Q38310393 | ||
| A PDZ-binding motif is essential but not sufficient to localize the C terminus of CFTR to the apical membrane | Q40828205 | ||
| Inhibition of thermolysin and human alpha-thrombin by cobalt(III) Schiff base complexes | Q41678159 | ||
| The relative binding affinities of PDZ partners for CFTR: a biochemical basis for efficient endocytic recycling | Q41893473 | ||
| Interaction of [Rh(2)(O(2)CCH(3))(4)(H(2)O)(2)] and [Rh(2)(O(2)CCH(OH)Ph)(2)(phen)(2)(H(2)O)(2)](O(2)C-CH(OH)Ph)(2) With Sulfhydryl Compounds and Ceruloplasmin | Q41979067 | ||
| A stabilizing influence: CAL PDZ inhibition extends the half-life of ΔF508-CFTR. | Q42031640 | ||
| Potent and selective peptidyl boronic acid inhibitors of the serine protease prostate-specific antigen | Q42177972 | ||
| Helix induction by dirhodium: access to biocompatible metallopeptides with defined secondary structure. | Q43089314 | ||
| Surface recognition of a protein using designed transition metal complexes | Q43654052 | ||
| Designing heterodimeric two-stranded alpha-helical coiled-coils. Effects of hydrophobicity and alpha-helical propensity on protein folding, stability, and specificity | Q44077318 | ||
| Metal ions as cofactors for the binding of inhibitors to methionine aminopeptidase: a critical view of the relevance of in vitro metalloenzyme assays | Q46478854 | ||
| Iridium complex with antiangiogenic properties. | Q54676811 | ||
| Influencing Receptor−Ligand Binding Mechanisms with Multivalent Ligand Architecture | Q56656697 | ||
| Proximity-driven metallopeptide catalysis: Remarkable side-chain scope enables modification of the Fos bZip domain | Q58482027 | ||
| Inhibition of Deamination of Arabinosylcytosine (NSC-63878) by Rhodium(II) Acetate | Q67353013 | ||
| Hydrophobicity of several rhodium(II) carboxylates correlated with their biologic activity | Q67587691 | ||
| The interaction of rhodium(II) carboxylates with enzymes | Q68208459 | ||
| Stabilization of the α-Helical Coiled-coil Domain in Laminin by C-terminal Disulfide Bonds | Q71849884 | ||
| Dirhodium(II,II) complexes: molecular characteristics that affect in vitro activity | Q79416353 | ||
| Association of the cystic fibrosis transmembrane regulator with CAL: structural features and molecular dynamics | Q81582178 | ||
| Controlling peptide structure with coordination chemistry: robust and reversible peptide-dirhodium ligation | Q84303921 | ||
| Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors | Q88519588 | ||
| P433 | issue | 29 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 7217-7220 | |
| P577 | publication date | 2012-06-14 | |
| P1433 | published in | Angewandte Chemie International Edition | Q62023953 |
| P1476 | title | Hybrid organic-inorganic inhibitors of a PDZ interaction that regulates the endocytic fate of CFTR. | |
| P478 | volume | 51 |
| Q41549856 | Assessing the intracellular fate of rhodium(ii) complexes |
| Q34066239 | Chemically modified peptide scaffolds target the CFTR-associated ligand PDZ domain |
| Q52689243 | Cysteine modifiers suggest an allosteric inhibitory site on the CAL PDZ domain. |
| Q27021652 | Getting in shape: controlling peptide bioactivity and bioavailability using conformational constraints |
| Q35582339 | Intracellular Delivery of Peptidyl Ligands by Reversible Cyclization: Discovery of a PDZ Domain Inhibitor that Rescues CFTR Activity |
| Q38314370 | Modulating protein-protein interactions: the potential of peptides |
| Q35235856 | Molecular recognition in protein modification with rhodium metallopeptides |
| Q45073074 | Potent and selective inhibition of SH3 domains with dirhodium metalloinhibitors |
| Q26866201 | Protein design: toward functional metalloenzymes |
| Q37295115 | Rhodium(II) Proximity-Labeling Identifies a Novel Target Site on STAT3 for Inhibitors with Potent Anti-Leukemia Activity |
| Q58482019 | Sequence-specific inhibition of a designed metallopeptide catalyst |
| Q91913292 | Specificity in PDZ-peptide interaction networks: Computational analysis and review |
| Q38539666 | Structure-Based Design of Inhibitors of Protein-Protein Interactions: Mimicking Peptide Binding Epitopes. |
Search more.